Abstract
The objective of this work was to investigate the influence of tablet location along the bottom of a USP apparatus II vessel on polymer erosion and drug release of surface-erodible sustained-release tablets using computational simulation methods. Computational fluid dynamics (CFD) methods were performed to simulate the velocity distribution. A mathematical model was developed to describe polymer erosion and tablet deformation according to the mass transfer coefficient. Numerical analysis was used to simulate drug release controlled by drug diffusion and polymer erosion. The results indicated that tablets located at the off-center position deformed faster than the tablets located at the center position. However, tablet location had no profound impact on drug release rate since all drug release profiles were “similar” according to the f2 similarity values which were above 50. Hence, our simulation supported that the USP apparatus II was a reliable and robust device for the dissolution testing of surface-erodible sustained-release tablets.
References
Qureshi SA, Shabnam J. Cause of high variability in drug dissolution testing and its impact on setting tolerances. Eur J Pharm Sci. 2001;12(3):271–6.
Baxter JL, Kukura J, Muzzio FJ. Hydrodynamics-induced variability in the USP apparatus II dissolution test. Int J Pharm. 2005;292(1):17–28.
Gao Z, Moore TW, Smith AP, Doub WH, Westenberger BJ. Studies of variability in dissolution testing with USP apparatus 2**Opinions expressed in this report are those of the authors and do not necessarily reflect the views or policies of the FDA. J Pharm Sci. 2007;96(7):1794–801.
Feng X, Zidan A, Kamal NS, Xu X, Sun D, Walenga R, et al. Assessing drug release from manipulated abuse deterrentformulations. AAPS PharmSciTech. 2020;21(2):40.
Meruva S, Rezaei L, Thool P, Donovan MD. Use of drug release testing to evaluate the retention of abuse-deterrent properties of polyethylene oxide matrix tablets. AAPS PharmSciTech. 2020;21(7):270.
Bai G, Armenante PM. hydrodynamic, mass transfer, and dissolution effects induced by tablet location during dissolution testing. J Pharm Sci. 2009;98(4):1511–31.
Zhang Y, Bredael G, Armenante PM. dissolution of prednisone tablets in the presence of an arch-shaped fiber optic probe in a USP dissolution testing apparatus 2. J Pharm Sci. 2013;102(8):2718–29.
Ameur H, Bouzit M. 3D hydrodynamics and shear rates’ variability in the United States Pharmacopeia paddle dissolution apparatus. Int J Pharm. 2013;452(1):42–51.
Cascone S. Modeling and comparison of release profiles: effect of the dissolution method. Eur J Pharm Sci. 2017;106:352–61.
Pham AT, Lee PI. Probing the mechanisms of drug release from hydroxypropylmethyl cellulose matrices. Pharm Res. 1994;11(10):1379–84.
Reynolds TD, Gehrke SH, Ajaz S. H, Shenouda LS. Polymer erosion and drug release characterization of hydroxypropyl methylcellulose matrices. J Pharm Sci. 1998;87(9):1115–23.
Katzhendler I, Hoffman A, Goldberger A, Friedman M. Modeling of drug release from erodible tablets. J Pharm Sci. 1997;86(1):110–5.
Zhou D, Law D, Reynolds J, Davis L, Smith C, Torres JL, et al. Understanding and managing the impact of HPMC variability on drug release from controlled release formulations. J Pharm Sci. 2014;103(6):1664–72.
USP, USP General Chapter <711> Dissolution, second supplement of USP 35-NF30. 2012.
Wang B, Bredael G, Armenante PM. Computational hydrodynamic comparison of a mini vessel and a USP 2 dissolution testing system to predict the dynamic operating conditions for similarity of dissolution performance. Int J Pharm. 2018;539(1):112–30.
Wang B, Armenante PM. Experimental and computational determination of the hydrodynamics of mini vessel dissolution testing systems. Int J Pharm. 2016;510(1):336–49.
Wilke CR, Chang P. Correlation of diffusion coefficients in dilute solutions. AICHE J. 1955;1(2):264–70.
Gao P, Fagerness PE. Diffusion in HPMC Gels. I. Determination of drug and water diffusivity by pulsed-field-gradient spin-echo NMR. Pharm Res. 1995;12(7):955–64.
Shah VP, Tsong Y, Sathe P, Liu JP. In vitro dissolution profile comparison—statistics and analysis of the similarity factor, f2. Pharm Res. 1998;15(6):889–96.
FDA, Guidance for industry SUPAC-MR: modified release solid oral dosage forms. 1997.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lou, H., Hageman, M.J. Investigating the Influence of Tablet Location Inside Dissolution Test Apparatus on Polymer Erosion and Drug Release of a Surface-Erodible Sustained-Release Tablet Using Computational Simulation Methods. AAPS PharmSciTech 22, 99 (2021). https://doi.org/10.1208/s12249-021-01979-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1208/s12249-021-01979-y